Company News and Media Resources

News Releases

October 1, 2020

Alucent Biomedical Announces $35 Million Series B Financing Press Release

May 27, 2020

Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial View

January 9, 2020

Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial View

September 25, 2018

Alucent Biomedical Announces Formation of Scientific Advisory Board View

Scientific and Clinical Presentations

Vascular Cures: Innovation spotlight – “Can We Make Stents Obsolete?” View

ACS 2020: Novel Sample Preparation Technique for Testing Biological Tissue via Differential Scanning Calorimetry Poster

ACS 2020: Photosensitized Tyrosine Dimerization Poster

MedTech Summit 2020 presentation:

JCTR 2020: Retained Functionality of Atherosclerotic Human Arteries Following Photoactivated Linking of Extracellular Matrix by Natural Vascular Scaffolding Treatment Read Article

ISET 2020: Natural Vascular Scaffolding for Treatment of Femoropopliteal Lesions in Peripheral Arterial Disease Poster

CRT 2020: Natural Vascular Scaffolding Promotes Post-Femoropopliteal PTA Patency Without Stent Implantation Abstract

AHA 2019: Effect of Natural Vascular Scaffolding (NVS) Treatment on Human Popliteal Arteries In Vitro Abstract / Poster

Media Resources

Alucent Biomedical

Corporate Fact Sheet View

NVS Restoration System Fact Sheet

The Alucent NVS Vessel Restoration System with Photoactivated Linking View

Alucent NVS Procedure Animation

Short video illustrating the NVS procedure View